Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Etoposide 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg

Reference Brands: Vepesid, Toposar (US)

Category: Oncology Cancer Care

Etoposide is used to treat different cancers of blood, lung, and testicles. It is also sometimes used to treat some other kinds of cancer in both men and women. It can be used on its own, or sometimes given together with certain other medicines as part of combination chemotherapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Etoposide — third party manufacturing & bulk supply

Etoposide 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Etoposide is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Etoposide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Etoposide →
Back to Listing

Frequently Asked Questions

Etoposide is listed as Injection in 100 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Etoposide is referenced against Vepesid, Toposar (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Etoposide

Strength:
50 mg

Form: Capsules

Reference Brands: Vepesid, Toposar (US)

View Details
Fludarabine Phosphate

Strength:
50 mg

Form: Injection

Reference Brands: Fludara (US/EU)

View Details
Epirubicin

Strength:
10 / 50 mg

Form: Injection

Reference Brands: Ellence (US), Farmorubicin (EU)

View Details
Enzalutamide

Strength:
40mg

Form: Capsules

Reference Brands: Xtandi (US/EU)

View Details
Epirubicin Hydrochloride

Strength:
10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL

Form: Injection (IV)

Reference Brands: Ellence® (US) , Farmorubicin®(EU)

View Details
Palonosetron Injection

Strength:
0.25 mg/5 mL (0.05 mg/mL)

Form: IV Injection

Reference Brands: Aloxi (US & EU)

View Details
Rucaparib Camsylate

Strength:
200 mg, 250 mg, 300 mg

Form: Oral tablets

Reference Brands: Rubraca® (EU & US)

View Details
Rituximab

Strength:
IV infusion: 100 mg/10 mL, 500 mg/50 mL; SQ: 1400 mg/11 mL

Form: IV Infusion; Subcutaneous

Reference Brands: Rituxan®(US), MabThera®, Truxima®(EU);Ruxience®(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.